Header Logo

Connection

KAREN H LU to Retreatment

Back to Details
This is a "connection" page, showing publications KAREN H LU has written about Retreatment.
KAREN H LU
Connection Strength
0.020
Retreatment
  1. A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma. Cancer. 2010 Dec 01; 116(23):5415-9.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.